165 related articles for article (PubMed ID: 38066224)
1. HER2 low expression breast cancer subtyping and their correlation with prognosis and immune landscape based on the histone modification related genes.
Li J; Yao J; Qi L
Sci Rep; 2023 Dec; 13(1):21753. PubMed ID: 38066224
[TBL] [Abstract][Full Text] [Related]
2. Colorectal cancer subtyping and immune landscape analysis based on natural killer cell-related genes.
Ding M; Gao J; Wang J; Li Z; Gong X; Cui Z; Li C; Xue H; Li D; Wang Y
Arab J Gastroenterol; 2024 May; ():. PubMed ID: 38719664
[TBL] [Abstract][Full Text] [Related]
3. Identification of Breast Cancer Immune-related Prognostic Characteristics in Tumor Microenvironment.
Tang Z; Li L; Huang X; Zhao Y; Liu Q; Zhang C
Recent Pat Anticancer Drug Discov; 2024 Jan; ():. PubMed ID: 38213151
[TBL] [Abstract][Full Text] [Related]
4. A novel liver zonation phenotype-associated molecular classification of hepatocellular carcinoma.
Zhang T; Gu J; Wang X; Lu Y; Cai K; Li H; Nie Y; Chen X; Wang J
Front Immunol; 2023; 14():1140201. PubMed ID: 36936935
[TBL] [Abstract][Full Text] [Related]
5. Construction of a prognostic model for breast cancer based on moonlighting genes.
Zhang M; Zhang D; Wang Q; Lin G
Hum Mol Genet; 2024 Mar; ():. PubMed ID: 38491801
[TBL] [Abstract][Full Text] [Related]
6. Human epidermal growth factor receptor 2 inhibits activating transcription factor 7 to promote breast cancer cell migration by activating histone lysine demethylase 1.
Lin J; Mao H; Ji Z; Lin W; Wang T
J Cancer Res Ther; 2021 Nov; 17(5):1192-1201. PubMed ID: 34850767
[TBL] [Abstract][Full Text] [Related]
7. Comprehensive analysis of tumor immune microenvironment and prognosis of m6A-related lncRNAs in gastric cancer.
Wang Y; Zhu GQ; Tian D; Zhou CW; Li N; Feng Y; Zeng MS
BMC Cancer; 2022 Mar; 22(1):316. PubMed ID: 35331183
[TBL] [Abstract][Full Text] [Related]
8. GNPNAT1 is a potential biomarker correlated with immune infiltration and immunotherapy outcome in breast cancer.
Yuan R; Zhang Y; Wang Y; Chen H; Zhang R; Hu Z; Chai C; Chen T
Front Immunol; 2023; 14():1152678. PubMed ID: 37215111
[TBL] [Abstract][Full Text] [Related]
9. Identification and exploration of the pyroptosis-related molecular subtypes of breast cancer by bioinformatics and machine learning.
Zhang L; Chu XF; Xu JW; Yao XY; Zhang HQ; Guo YW
Am J Transl Res; 2022; 14(9):6521-6535. PubMed ID: 36247248
[TBL] [Abstract][Full Text] [Related]
10. Integrating Bioinformatics and Drug Sensitivity Analyses to Identify Molecular Characteristics Associated with Targeting Necroptosis in Breast Cancer and their Clinical Prognostic Significance.
Zheng C; Guo H; Mo Y; Liu G
Recent Pat Anticancer Drug Discov; 2023 Aug; ():. PubMed ID: 37653627
[TBL] [Abstract][Full Text] [Related]
11. Key Genes and Prognostic Analysis in HER2+ Breast Cancer.
Weng Y; Liang W; Ji Y; Li Z; Jia R; Liang Y; Ning P; Xu Y
Technol Cancer Res Treat; 2021; 20():1533033820983298. PubMed ID: 33499770
[TBL] [Abstract][Full Text] [Related]
12. Identification of a pyroptosis-related prognostic signature in breast cancer.
Chen H; Luo H; Wang J; Li J; Jiang Y
BMC Cancer; 2022 Apr; 22(1):429. PubMed ID: 35443644
[TBL] [Abstract][Full Text] [Related]
13. ADRB1 was identified as a potential biomarker for breast cancer by the co-analysis of tumor mutational burden and immune infiltration.
Wang J; Zhang X; Li J; Ma X; Feng F; Liu L; Wu J; Sun C
Aging (Albany NY); 2020 Nov; 13(1):351-363. PubMed ID: 33234738
[TBL] [Abstract][Full Text] [Related]
14. Identification of immunological characterization and Anoikis-related molecular clusters in rheumatoid arthritis.
Zhao J; Wei K; Shi Y; Jiang P; Xu L; Chang C; Xu L; Zheng Y; Shan Y; Liu J; Li L; Guo S; Schrodi SJ; Wang R; He D
Front Mol Biosci; 2023; 10():1202371. PubMed ID: 38046810
[No Abstract] [Full Text] [Related]
15. Identification of prognostic biomarkers of breast cancer based on the immune-related gene module.
Wang R; Zeng H; Xiao X; Zheng J; Ke N; Xie W; Lin Q; Zhang H
Autoimmunity; 2023 Dec; 56(1):2244695. PubMed ID: 37584152
[TBL] [Abstract][Full Text] [Related]
16. Prognostic Value and Genome Signature of m6A/m5C Regulated Genes in Early-Stage Lung Adenocarcinoma.
Tian L; Wang Y; Tian J; Song W; Li L; Che G
Int J Mol Sci; 2023 Mar; 24(7):. PubMed ID: 37047493
[TBL] [Abstract][Full Text] [Related]
17. An Intratumor Heterogeneity-Related Signature for Predicting Prognosis, Immune Landscape, and Chemotherapy Response in Colon Adenocarcinoma.
Liu C; Liu D; Wang F; Xie J; Liu Y; Wang H; Rong J; Xie J; Wang J; Zeng R; Zhou F; Xie Y
Front Med (Lausanne); 2022; 9():925661. PubMed ID: 35872794
[TBL] [Abstract][Full Text] [Related]
18. Performance of a PLK1-based immune risk model for prognosis and treatment response prediction in breast cancer.
Chen Y; You Y; Wu Q; Wu J; Lin S; Sun Y; Cui Z
Cancer Med; 2023 May; 12(9):11020-11039. PubMed ID: 36951624
[TBL] [Abstract][Full Text] [Related]
19. Integrated pancancer analysis reveals the oncogene characteristics and prognostic value of DIP2B in breast cancer.
Song C; Shang F; Tu W; Liu X
BMC Cancer; 2023 Mar; 23(1):296. PubMed ID: 37004015
[TBL] [Abstract][Full Text] [Related]
20. Prognostic and immune infiltration features of disulfidptosis-related subtypes in breast cancer.
Chen S; Li X; Ao W
BMC Womens Health; 2024 Jan; 24(1):6. PubMed ID: 38166898
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
